Scientists can depend on a formidable tool — light — when it comes to recording and stimulating brain activity. An international team of researchers, directed by Istituto Italiano di Tecnologia (Italian Institute of Technology/IIT), has created nanometric light modulators that, built on a micrometric optical fiber, make the fiber capable of analyzing neuronal tissue in deep regions of the brain.
The new method, reported in Advanced Optical Materials and presented on the journal’s front cover, lays the foundation for a ground-breaking type of minimally invasive neural probe that can be used to examine the central nervous system. The nanomodulators will be used to explore particular brain diseases, including epilepsy and brain tumors.
The research was performed by IIT in partnership with the University of Salento (Italy), the Politecnico of Bari (Italy), the Consejo Superior de Investigaciones Cientificas (CSIC, Spain) and the Centro National de Investigaciones Oncologicas (CNIO, Spain).
In Italy, the interdisciplinary team was focused on obtaining micrometric structures that are capable of examining neuronal tissue in a thorough way using light, i.e., through the integration of optical nanomodulators.
To achieve this, researchers integrated expertise in nanoscale fabrication and biomedical neuro-engineering, so as to manipulate the physics of surface plasmon polaritons and develop an investigative tool that adjusts and amplifies the way light can excite and monitor particular areas of the brain.
They began from a tapered optical fiber, thinner than a hair, and then they fitted it with nanostructures that resonate in reaction to a light stimulus added by the fiber itself into the deep brain regions.
The nanostructures were developed by coating the microscopic tip of the probe with a thin layer of gold. Then, using a gallium ion beam as a chisel, they fashioned a grid of nanoscopic optical elements, comprising 100 nm thin lines, whose features were confirmed in a series of microscopy and optical spectroscopy experiments.
As a result of this production technique, it was possible to acquire a tool that allows both the probe light beam modulation and the local electric field acting on surfaces comparable to the size of brain cells to be regulated. Scientists may be able to then explore the interaction between the light beam and neuronal structures, even in the deepest areas of the brain.
The possibility of developing such implantable plasmonic systems provides a new perspective in the research of the central nervous system: the amplification created by the nanostructures is meant to be an efficient tool for sensing the biochemical and cellular structure changes underlying the source of numerous neural disorders.
Thus, the part of the international team working out of Spain is concentrating on the application, it may have. Experimental scientists at CSIC led by Liset M de la Prida are aiming to apply these probes in the exploration of post-traumatic epilepsy and neurodegenerative diseases, for example, Alzheimer’s disease.
While the Brain Metastasis Group directed by Manuel Valiente at the CNIO will explore the use of this new technology to differentiate primary from metastatic tumors, whose treatments are diverse, as well as the use of light to permeabilize the blood-brain barrier, permitting anti-tumor drugs to travel via the vascular barrier.
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
